Document wqnDM8B10BZG6d7dDdMq4eXBd
To: From:
Cc: Bcc: Received Date: Subject:
Colmer, Robert W SC-DCS/18 <Rob.Colmer@shell.com> Clegg, Patsy M SCC-DCS/22 <lO=SHELLlOU=MSXSCC/CN=RECIPIENTS/CN=PH197432>
2007-04-1813:47:45 GMT FW: Shanghai Health Study Update
-----Original Message-----
From:
Clegg, Patsy M SCC-DCS/22
Sent:
Tuesday, April 17, 2007 9:41 AM
To: Methvin, Stacy P SCC-DCA; Williams, Charlie CR SIEP-EPT-RL; Simpson, Edward J SCC-DCAl2
Cc: Snyder, Phil J SDIUS-DXXl9; Sykes, Paul B SCC-DCS/23; Williams, Elizabeth J SCAI-DCS/22;
Cagen, Stuart Z SHLOIL-SHOIL-SHS; Tsai, Shan P SHLOIL-SHS; Semmler, Klaus K DSC-DCS/235
Subject:
Shanghai Health Study Update
Progress is being made towards establishing a new contract with CinPathogen and extending the University of Colorado grant to support finishing the Shanghai Health Study. Key issues include providing advance funding to keep the lab operating while new contracts are being established and developing specific deliverables and timelines for the new contract and grant. All sponsors have executed contract amendment 4 agreeing to additional funding.
Timeline for the study:
June 30 07
December 31 07
(formerly NHL) case accrual
2008
publications will continue beyond 08)
December 31 08
disbands
End AML case accrual End lymphoid neoplasms
Data analysis and publications (some
Study ends; consortium
Key events are listed below.
April 11:
API Executive Committee reached consensus on
(1) supporting the advance of $800K to Dr. Irons providing that he
agrees to certain terms. No additional funds until contract is in place. Attached is
the letter that Red Cavaney sent to Dr. Irons.
being met.
(2) funding throgh CinPathogen conditional on all API contract criteria The draft list of action items from the meeting:
April 16:
Dr. Irons sined letter. API wired $800K to CinPathogen. Irons isgned
letter on April 12; IT challenges in transmitting to API.
Consortium conference call to further develop list of deliverables to
support items in Irons/APlletter. API has discussed with Irons, so
understanding and agreement can be more quickly achieved.
April 26
Consortium call scheduled to finalize deliverables and get up
update on API contracting criteria being met.
SHELL-MCCLURG-060126
I will keep you updated. Happy to address any questions or comments. Patsy Clegg Product Steward Shell Chem ical LP One Shell Plaza, 910 Louisiana, Houston, TX 77002-4916 Tel: +1 713241 2521 Fax: 3325 Email: patsy.clegg@shell.com Internet: http://www.shell.com/chemicals Attachments: 41107_RCLettertoRI rons. pdf Action Items - draft.ZIP
SHELL-MCCLURG-060127